Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
Carcinogenesis
|
June 12, 2008
Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells
Jen-Chung Ko, Shih-Ci Ciou, Chau-Ming Cheng, et al.
Experimental Cell Research
|
February 10, 2015
Down-regulation of ERK1/2 and AKT-mediated X-ray repair cross-complement group 1 protein (XRCC1) expression by Hsp90 inhibition enhances the gefitinib-induced cytotoxicity in human lung cancer cells
Chun-Liang Tung, Yi-Jun Jian, Jhan-Jhang Syu, et al.
Biochemical Pharmacology
|
December 12, 2012
Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel
Sheng-Chieh Tseng, Yu-Ching Huang, Huang-Jen Chen, et al.
Molecular Cancer Therapeutics
|
November 13, 2008
Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
Jen-Chung Ko, Jhao-Hao Hong, Lyu-Han Wang, et al.
Biochemical Pharmacology
|
September 27, 2016
Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression
Jen-Chung Ko, Hao-Yu Zheng, Wen-Ching Chen, et al.
Pharmacology
|
June 29, 2018
17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human Lung Squamous Cell Carcinoma Cells
Jyh-Cheng Chen, Peng-Fang Ma, Yuan-Cheng Lin, et al.
Toxicology Research
|
December 18, 2018
Astaxanthin enhances erlotinib-induced cytotoxicity by p38 MAPK mediated xeroderma pigmentosum complementation group C (XPC) down-regulation in human lung cancer cells
Jyh-Cheng Chen, Chia-Hung Wu, Yi-Shuan Peng, et al.
Toxicology Research
|
May 5, 2022
Nitroglycerin-induced downregulation of AKT- and ERK1/2-mediated radiation-sensitive 52 expression to enhance pemetrexed-induced cytotoxicity in human lung cancer cells
Jen-Chung Ko, Jyh-Cheng Chen, Pei-Yu Tseng, et al.
Chinese Journal of Natural Medicines
|
June 22, 2013
Transformation of strictosamide to vincoside lactam by acid catalysis
Zhao-Qing Meng, Wen-Jun Liu, Zan Li, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
March 31, 2016
Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells
Chun-Liang Tung, Yi-Jun Jian, Jyh-Cheng Chen, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
Carcinogenesis
|
June 12, 2008
Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells
Jen-Chung Ko, Shih-Ci Ciou, Chau-Ming Cheng, et al.
Experimental Cell Research
|
February 10, 2015
Down-regulation of ERK1/2 and AKT-mediated X-ray repair cross-complement group 1 protein (XRCC1) expression by Hsp90 inhibition enhances the gefitinib-induced cytotoxicity in human lung cancer cells
Chun-Liang Tung, Yi-Jun Jian, Jhan-Jhang Syu, et al.
Biochemical Pharmacology
|
December 12, 2012
Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel
Sheng-Chieh Tseng, Yu-Ching Huang, Huang-Jen Chen, et al.
Molecular Cancer Therapeutics
|
November 13, 2008
Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
Jen-Chung Ko, Jhao-Hao Hong, Lyu-Han Wang, et al.
Biochemical Pharmacology
|
September 27, 2016
Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression
Jen-Chung Ko, Hao-Yu Zheng, Wen-Ching Chen, et al.
Pharmacology
|
June 29, 2018
17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human Lung Squamous Cell Carcinoma Cells
Jyh-Cheng Chen, Peng-Fang Ma, Yuan-Cheng Lin, et al.
Toxicology Research
|
December 18, 2018
Astaxanthin enhances erlotinib-induced cytotoxicity by p38 MAPK mediated xeroderma pigmentosum complementation group C (XPC) down-regulation in human lung cancer cells
Jyh-Cheng Chen, Chia-Hung Wu, Yi-Shuan Peng, et al.
Toxicology Research
|
May 5, 2022
Nitroglycerin-induced downregulation of AKT- and ERK1/2-mediated radiation-sensitive 52 expression to enhance pemetrexed-induced cytotoxicity in human lung cancer cells
Jen-Chung Ko, Jyh-Cheng Chen, Pei-Yu Tseng, et al.
Chinese Journal of Natural Medicines
|
June 22, 2013
Transformation of strictosamide to vincoside lactam by acid catalysis
Zhao-Qing Meng, Wen-Jun Liu, Zan Li, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
March 31, 2016
Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells
Chun-Liang Tung, Yi-Jun Jian, Jyh-Cheng Chen, et al.
Page
of 6